Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Atrium Innovations Inc ATBIF

Healthcare Drug Manufacturers - Specialty & Generic

GREY:ATBIF - Post Discussion

Atrium Innovations Inc > Technical breakout
View:
Post by traderates on Jan 27, 2013 4:05pm

Technical breakout

ATB is looking healthy from a chart perspective.  Been following for years and bougt in after the double bottom held and earnings beat.  Blue sky ahead.  Hard to believe they haven't been bought out by now.

Herbalife gong show is good for ATB.  Strong Euro rebound will boost earnings next quarter.

Good luck all.

Comment by shallett on Feb 07, 2013 9:42pm
ATB has the ability to rally MUCH MUCH higher if management were to decide to leave the status quo and get on the offensive.  Aside from selling the company (for potentially 3 x the current sp): 1)  They need to introduce 2013 EPS guidance (and then beat it).  Analyst estimates are way too low IMO. 2)  NHS needs to be classifed as discontinued ops to give investor's a ...more  
Atrium Innovations Inc